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Figure: Scheme of the hybrid system (as operated at the 
Charité Universitätsmedizin Berlin: BSD-2000/3D/MRI in a 
1.5T Siemens Symphony) for clinical use (upper part) in 
contrast to a prototype of an integrated system for 
experimental purposes (developed at the Max-Delbrück 
Center Berlin: 7T Siemens Magnetom), see Winter 2016. 
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Purpose: During proton therapy, patients receive undesired 
dose from neutrons produced in beam line components or in 
the patient. The neutron dose is primarily a concern related 
to long-term consequences such as radiation-induced 
secondary cancers. The majority of existing experimental 
data is based on measurements with passive detectors or 
measurements in air, and most studies have been performed 
in passive scattering- or uniform scanning beam lines. The 
aim of this study was to investigate the neutron dose from 
Pencil Beam Scanning (PBS) proton therapy by in-phantom 
measurements with a novel active neutron detector.  
Materials/Methods: Measurements of the neutron fluence 
were performed at several positions inside a water phantom 
irradiated by a 178 MeV proton pencil beam at The Svedberg 
Laboratory in Uppsala, Sweden. The measurements were 
conducted with a recently developed neutron detector based 
on registration of single event upsets in static random access 
memories (SRAMs). Fluka Monte Carlo simulations were 
performed and compared to the measurements. The results 
were also compared to previously published neutron doses 
measured under similar experimental conditions. Fluence-to-
dose conversion factors from ICRP were applied to calculate 
neutron ambient dose equivalent (H*(10)).  
Results: The measurements indicated that the neutron dose 
at the Bragg peak depth decreased exponentially from 0.17 
pSv/proton to 0.03 pSv/proton from 5 cm to 14 cm lateral 
distance from the beam axis inside the water phantom (Table 
I). For an extended target volume of 3x3x3 cm3, this 
corresponds to neutron doses ranging from approximately 1 
mSv/Gy to 0.1 mSv/Gy. The neutron dose varied only to a 
small degree with depth in the phantom. The measurements 
and simulations showed similar relative distributions of 
neutron dose, but the simulations predicted overall lower 
doses, typically by a factor two. The experimental values 
were in relatively good agreement with previous results in 
the literature. 
Conclusions: The neutron dose in the water phantom from 
the proton pencil beam was measured to be on the order 1 
mSv/Gy at 5 cm lateral distance from the primary beam axis 
at the Bragg peak depth, while decreasing to approximately 
0.1 mSv at 14 cm lateral distance. Variation in neutron dose 
as a function of depth in the water phantom was modest. The 
results demonstrate the feasibility of using the SRAM 
detector for in-phantom measurements, and can be applied 
in estimation of secondary cancer risk from PBS proton 
therapy. 
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In view of the growing trend in personalizing medicine and 
with the development of sophisticated equipment and 
algorithms for guiding radiotherapies, more precise doses 
and/or particle beams can be delivered to the target tumor 
while minimizing side effects to the surrounding healthy 
tissue, which opened up access to new delivery modalities 
and clinical protocols. Although many clinical studies are 
trying to evaluate the differential effects between different 
types of radiotherapy on patients’ outcomes, the biological 
response at the cellular level, and the different cellular 
pathways involved, are yet inadequately be explored. Novel 
technologies to evaluate genomics or proteomics-based 
effects in tumor tissue, but also in bodily fluids, have 
revealed molecular information that will open the doors for 
new clinical understanding in Oncology. This lecture will 
discuss these omics applications in the context of the most 
recent technologies. 
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In radiotherapy, dose calculation algorithms are used to 
calculate dose distribution in human body. 
Different algorithms are used by several treatment planning 
and differ in the accuracy of dose calculation.    
In this study, a dose calculation accuracy of two commercial 
treatment planning systems (TPS) were evaluated regarding 
Monte Carlo method.  
The Linac head of Primus Simens was modeled using MCNPX 
Monte Carlo code based on manufacturer information. Four 
analytic dose calculation algorithms including PBC, AAA from 
Eclipse TPS, convolution and superpostion from XiO 
treatment planning system were evaluated for a small solid 
tumor in lung. A solid tumor with diameter of 1.8 cm was 
considered in a thorax phantom and calculations was 
performed for 1×1, 2×2, 3×3, 4×4 cm2 field sizes for 6MV and 
18 MV energies. The results of TPSs were compared with the 
results of MC method as a most reliable method. 
A dose overestimation of up to 110% inside lung region and 
25% for tumor was found for field size of 1×1 cm in the 18 MV 
photon beam for PBC and convolution methods, comparing to 
MC results. 
For AAA, superposition a close agreement was seen with 
Monte Carlo simulation in all studied field sizes. 
Our results showed that the PBC and convolution methods 
overestimate the lung dose as well as the solid tumor dose 
significantly and large errors could arise in treatment plans 
of lung region and change the outcome of treatment. The 
Use of MC based methods, AAA and superposition methods 
are recommended for lung treatments with small fields.  
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Purpose: The purpose of the presented research is the 
development of the new type of device being a mobile 
(portable) and flexible (adaptable) PET scanner, which will 
play a role of an insert to the existing MR scanners, providing 
a unique worldwide solution for simultaneous (at the place 
and time) functional and anatomical PET-MRI imaging. 
Material and methods: Presented solution of a mobile-PET 
scanner will enable simultaneous registration of PET and MRI 
images utilizing existing MRI scanners, without need of any 
modifications. The developed device is based on the strip-
PET concept [1-4], consisting of individual detection 
modules, each build from a plastic scintillator strip 
connected optically at both ends with the photoelectric 
converter. In the proposed solution we utilize the array of 
the silicon photomultipliers which plays a role of light to 
electric signal converter. The signal readout and processing 
system together with the fast front end electronic modules 
will allow to reconstruct time and place of the annihilation 
[5,6]. In the proposed solution determination of the point of 
annihilation along the direction of the gamma quanta flight 
path, is based on the time difference registered in various 
detection modules.  
It is important to stress that the utilized silicon 
photomultipliers are insensitive to the MR scanner magnetic 
field therefore its work will not be disturbed with the 
presence of high magnetic field. Also small electronic 
elements will not cause the inhomogeneity of the magnetic 
field in the diagnosed volumes. Important from the point of 
view of the simultaneous PET/MRI diagnosis is a matter of 
positioning of two tomographic images with respect to each 
other. Therefore we will implement the method of 
positioning by usage of watermarks, seen by MRI system. For 
the proposed mobile PET scanner this method appears to be 
effective and at the same time simplest solution of this 
problem. Since this method explicitly specify the position of 
the MRI with respect to PET scanner therefore it enables to 
synchronize both tomographic images. 
The advantage of this solution is the elimination of artifacts 
in tomographic images hindering the identification of 
potentially cancerous lesions. At the same time, the 
proposed solution allows using the existing MRI scanners 
currently held by hospitals, without interfering in their 
structure and parameters, which should significantly improve 
the availability of this combined diagnostic method, taking 
into account the lower cost of such adaptation in relation to 
the market price of a new PET-MRI device. 
Conclusion: In the talk we will present developed solution of 
a mobile-PET insert to MR scanners.  The presentation will 
include the characteristics of a proposed device together 
with the advantages over present solutions [7].  
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